IVAN Institute | Center for Implementation Research

IVAN RESEARCH INSTITUTE

At the forefront of cutting-edge research and innovation, committed to advancing knowledge and improving lives.

Learn More & Apply

At the forefront of cutting-edge research and innovation, committed to advancing knowledge and improving lives.

At the forefront of cutting-edge research and innovation, committed to advancing knowledge and improving lives.

VISION STATEMENT

A global leader in transformative research, inspiring a future where innovation, ethical values, and accountability converge to shape groundbreaking solutions for the betterment of society

MISSION STATEMENT

We are dedicated to advancing knowledge and impacting lives through rigorous research and innovation.
Guided by our core values, we commit to…

KEY AREAS OF FOCUS

Pioneering research in oncology Driving innovation and implementation in research methodologies

Ensuring strategic integration of research initiatives across medical disciplines…

Unique Research Institute

Engaging in research activities gives you the chance to improve your research abilities, learn new techniques, and get feedback on your plans. It also allows you to share research ideas and updates with others.

About Us

IVAN Institute has developed sustained collaborations with institutions such as the Michigan State University, University of California San Diego (UCSD), the John Hopkins University (JHU), Duke University, and Oregon Health Sciences University (OHSU) and Monash University, Australia. These collaborations have successfully attracted research grants, thus advancing clinical trials and implementation research in healthcare for enhanced patient well-being.

Research

Establish a national and international recognized center for translation and Implementation research focused on skill training, community engagement, and research advancement

Publications

Nigeria offers universal hepatitis B birth-dose vaccine (HepB-BD) for the prevention and control of hepatitis B (HepB). While prior studies suggest low coverage of HepB-BD in Nigeria.